In addition, angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) are two commonly prescribed medications for the management of HTN, and since SARS-CoV-2 binds to ACE2 in the lung, some theories have been raised about the benefits of these medications in the treatment of COVID-19 [24]. Here, ACE is linked to COVID-19.